MedPath
HSA Approval

ENOXAPARIN SANDOZ SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 6,000 IU (60 MG)/ 0.6 ML

SIN17086P

ENOXAPARIN SANDOZ SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 6,000 IU (60 MG)/ 0.6 ML

ENOXAPARIN SANDOZ SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 6,000 IU (60 MG)/ 0.6 ML

September 11, 2024

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

SUBCUTANEOUS, INTRAVASCULAR, INTRAVENOUS BOLUS

Medical Information

B01AB05

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

ROVI PHARMA INDUSTRIAL SERVICES, S.A. (Julián Camarillo)

Active Ingredients

Enoxaparin Sodium

6,000 IU (60 MG) /0.6 ML

Enoxaparin sodium

Documents

Package Inserts

Enoxaparin Sandoz PI September 2024.pdf

Approved: September 11, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ENOXAPARIN SANDOZ SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 6,000 IU (60 MG)/ 0.6 ML - HSA Approval | MedPath